FilingSEC EDGAR6-K/A
Quantum Biopharma Files 6-K/A to Incorporate Exhibit
· SEC accepted
Filing content
Quantum Biopharma filed an amendment to its 6-K report to incorporate an exhibit into its registration statement.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…